Unit: Market Access Consulting
Subject: Evaluation of the price negotiations of pharmaceuticals in the framework of the benefit assessment (section 35a SGB V)
Target group: Representatives of the pharmaceutical industry, consultants
Method: Individual telephone interviews
Sample: N = 10
Report: Market Access Compass 2014 - Paths through the price negotiations with the GKV head organization
Year: 2014